Cellebrite DI (CLBTW) Institutional Ownership → The Gold Grab of the Century (From Colonial Metals) (Ad) Free CLBTW Stock Alerts $2.11 +0.07 (+3.43%) (As of 04/26/2024 08:52 PM ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Cellebrite DI (NASDAQ:CLBTW)Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$526.73KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$477.46K Get CLBTW Insider Trade Alerts Want to know when executives and insiders are buying or selling Cellebrite DI stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CLBTW Institutional Buying and Selling by Quarter Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. Cellebrite DI Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/11/2023Crescent Park Management L.P.549,432$681K0.2%+3.3%0.000% 8/1/2023Arena Capital Advisors LLC CA182,722$227K0.8%-57.1%0.000% 5/23/2023Greenhaven Road Investment Management L.P.2,657,090$2.29M1.3%-3.7%0.000% 5/16/2023Fort Baker Capital Management LP559,518$481K0.1%N/A0.000% 5/16/2023Greenhaven Road Investment Management L.P.2,657,090$2.29M1.3%-3.7%0.000% 5/11/2023Crescent Park Management L.P.531,887$457K0.1%+5.5%0.000% 2/16/2023Josh Arnold Investment Consultant LLC819,250$506K0.7%N/A0.000% (Data available from 1/1/2016 forward) CLBTW Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CLBTW shares? During the previous two years, the following institutional investors and hedge funds held shares of Cellebrite DI shares: Greenhaven Road Investment Management L.P. ($2.29M), Crescent Park Management L.P. ($681K), Josh Arnold Investment Consultant LLC ($506K), and Fort Baker Capital Management LP ($481K), Arena Capital Advisors LLC CA ($227K).Learn more on CLBTW's institutional investors. Which institutional investors have been buying Cellebrite DI stock? The following institutional investors have purchased Cellebrite DI stock in the last 24 months: Josh Arnold Investment Consultant LLC ($819.25K), Fort Baker Capital Management LP ($559.52K), and Crescent Park Management L.P. ($45.21K). How much institutional buying is happening at Cellebrite DI? Institutional investors have bought a total of 1,423,979 shares in the last 24 months. This purchase volume represents approximately $1.03M in transactions. Which Cellebrite DI major shareholders have been selling company stock? The following institutional investors have sold Cellebrite DI stock in the last 24 months: Arena Capital Advisors LLC CA ($243.67K), and Greenhaven Road Investment Management L.P. ($203.85K). How much institutional selling is happening at Cellebrite DI? Institutional investors have sold a total of 447,520 shares in the last 24 months. This volume of shares sold represents approximately $477.46K in transactions. Related Companies: AVPTW Institutional Ownership GRRRW Institutional Ownership KPLTW Institutional Ownership NNAVW Institutional Ownership PGYWW Institutional Ownership PAYOW Institutional Ownership ALLG Institutional Ownership ASTSW Institutional Ownership AUROW Institutional Ownership RAAS Institutional Ownership This page (NASDAQ:CLBTW) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellebrite DI Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.